Lv591
1108 积分 2023-05-31 加入
从事CAR-T行业
Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs
1个月前
已关闭
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors
1个月前
已完结
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy
1个月前
已完结
Combination of oncolytic viruses and immune checkpoint inhibitors for treatment of high-grade gliomas
2个月前
已完结
Enhanced antitumor efficacy of next-generation B7-H3 chimeric antigen receptor T cells containing CD28, CD137 and CD27 costimulatory domains in multiple myeloma
3个月前
已完结
Microbiota-induced T cell plasticity enables immune-mediated tumour control
3个月前
已完结
Immune Checkpoint Inhibitors: Basics and Challenges
4个月前
已完结
iRECIST: assessment of immunotherapy response
4个月前
已完结
Systematic discovery of CRISPR-boosted CAR T cell immunotherapies
6个月前
已完结
皖公网安备34019202002308
